Therefore, future studies are warranted to demonstrate the role of Nrf2 in regulating xCT expression and/or activity in glioma, as augmented levels of glutamate may facilitate tumor growth by eliciting neuronal damage. Here, SLC7A11 is linked to central nervous system cancer.